SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. It develops and provides a whole-body portable ultrasound scanner called the iQ Device and related hosted, web-based application, application programming interfaces and platform services, which the firm offer to physicians or other licensed health care providers. Its products include iQ+ Ultrasound, Butterfly Enterprise and iQ Vet. The company was founded by Jonathan M. Rothberg on January 25, 2011 and is headquartered in Burlington, MA.

Butterfly Network Inc - Ordinary Shares - Class A

Butterfly Network Inc

Butterfly Network is trending after surging on strong earnings and revenue growth, fueled by an AI partnership with Midjourney that has sparked investor excitement around its ultrasound-on-chip technology. The community is actively debating the stock's long-term potential as a semiconductor play versus concerns over ongoing cash burn and the risk of share dilution.

The 401jK (just kidding) meme is a satirical punch in the gut in the face of the concept of retirement and the popular US based 401(k) retirement plan and other pension plans around the world  Through the meme fueled humor, irony, satire &amp; inspiration from cypherpunk ideology, real life data, and current events... the 401jK community aims to comment on the fact that global markets are heavily manipulated for selfish purposes by the same people who control these pension funds... while also aiming to twist the heads of the 401k and global pension systems.  It is a retirement plan that seeks to make social, political, economic commentary fueled by the memes and dreams of the hive mind of the community that makes up 401jK  The rules have changed, and the game was always rigged.  It's time to wake up, adapt, rebel, and heal.  Welcome to 401jK

401jK

The 401JK community is generating significant buzz ahead of an upcoming NFT drop, with supporters framing the project as a grassroots 'pure belief' asset designed to mock the traditional, rigid retirement system. While the project faces skepticism from critics citing past volatility and rug-pull concerns, the community maintains high conviction, actively promoting their 'Resist & Retire' narrative through viral memes and IRL raids.

American Airlines Group, Inc. is a holding company, which engages in the operation of a network carrier through its principal wholly owned mainline operating subsidiary, American. The firm offers air transportation for passengers and cargo. It operates through the following geographical segments: Domestic, Latin America, Atlantic, and Pacific. The company was founded on December 9, 2013, and is headquartered in Fort Worth, TX.

American Airlines Group Inc

American Airlines is trending as investors weigh strong travel demand against significant operational headwinds, including elevated fuel costs linked to Middle East geopolitical instability. The community is actively debating the potential market share gains from Spirit Airlines' wind-down, contrasted with concerns over American's high debt levels and the risk of financial distress.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin is trending as investors focus on upcoming catalyst milestones, including a high-stakes Supreme Court patent case and ongoing clinical data readouts. The community remains actively split, with discussions weighing potential takeover scenarios against long-term concerns regarding management execution and the company's sole-drug reliance.

Lumen Technologies, Inc. is an investment holding company, which engages in the provision of integrated communications to residential and business customers. It operates through the Business and Mass Markets segments. The Business segment provides products and services under four sales channels to enterprise and commercial customers. The Mass Markets segment focuses on consumer and small business customers. The company was founded in 1930 and is headquartered in Monroe, LA.

Lumen Technologies Inc

Lumen Technologies is trending as investors weigh its pivot toward AI-driven infrastructure against lingering concerns about legacy revenue and high debt. The community is sharply divided, with many bullish on recent fiber expansion deals and NaaS growth, while others remain skeptical until management delivers sustainable top-line revenue improvement.

Ardelyx, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Its products include IBSRELA and XPHOZAH. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is trending as investors react to strong quarterly growth and ongoing market speculation surrounding potential acquisition interest from Zydus Lifesciences. The community is actively debating the company's long-term valuation and the impact of the ongoing CMS litigation on the commercial outlook for Xphozah.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is currently trending as shareholders analyze the company's recent lack of corporate communications, while simultaneously speculating on an upcoming July announcement regarding global expansion and potential partnerships. Community discourse remains heavily focused on the stock's high short interest, the perceived suppression by Big Pharma and the FDA, and the potential for a significant price movement following expected Q2 revenue updates.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Sea Ltd is capturing intense investor focus ahead of its upcoming earnings report, with the community actively debating whether the stock's recent volatility represents a structural value play or a deeper fundamental disconnect. Traders are closely monitoring key support levels and management's strategic pivot toward AI-integrated operations, while discussions highlight a stark contrast between those betting on a major breakout and those wary of regional competitive pressures.

MercadoLibre, Inc. engages in the development of an online commerce platform with a focus on e-commerce and related services. It operates through the following geographical segments: Brazil, Argentina, Mexico, and Other Countries. The Other Countries segment refers to Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Panama, Peru, Bolivia, Honduras, Nicaragua, El Salvador, Guatemala, Paraguay, Uruguay, and the United States of America. Its products provide a mechanism for buying, selling, and paying as well as collecting, generating leads, and comparing lists through e-commerce transactions. The company was founded by Marcos Eduardo Galperin on October 15, 1999 and is headquartered in Montevideo, Uruguay.

MercadoLibre Inc

MercadoLibre is currently trending due to a sharp sell-off following a mixed earnings report, where strong revenue growth and ecosystem expansion were overshadowed by investor concerns over margin pressure and heavy strategic reinvestment. The community is actively debating whether this pullback represents a classic buying opportunity for a long-term compounder or a sign of weakening structural profitability amid increasing competition.

The Render Network is a leading decentralized GPU compute platform for applications ranging from 3D rendering to machine learning and generative AI.  The network connects node operators looking to monetize their idle GPU compute power with artists and developers looking to scale intensive 3D rendering work and machine learning applications in the cloud. Through a decentralized peer-to-peer network, the Render Network achieves unprecedented levels of scale, speed, and economic efficiency. Facilitated by the Render Network Foundation, the ecosystem empowers artists and developers to build services and applications for the emerging digital economy.

Render Token (SOL)

Render is capturing significant community attention as a foundational DePIN and AI infrastructure play, with investors focusing on its role in providing decentralized GPU compute power. While some participants express frustration over recent price volatility, many are using the current dips to accumulate, viewing the project as a long-term utility asset positioned to capitalize on the increasing global demand for high-performance computing.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

After Plunging 22.6% in 4 Weeks, Here's Why the Trend Might Reverse for Microbot Medical (MBOT)

Microbot Medical (MBOT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Microbot Medical Inc. (MBOT) Reports Q1 Loss, Misses Revenue Estimates

Microbot Medical (MBOT) delivered earnings and revenue surprises of +37.50% and -76.67%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Microbot Medical (MBOT) to Release Quarterly Earnings on Wednesday

Microbot Medical (NASDAQ:MBOT) will be releasing earnings after the market closes on Wednesday, May 13. (View Earnings Report at...

Cencora to Report Q2 Earnings: What's in Store for the Stock?

COR heads into Q2 earnings with expected steady specialty-driven growth, but customer losses and pricing pressures could temper results.

Solventum to Post Q1 Earnings: Is a Beat Likely for the Stock?

SOLV gears up for Q1 earnings with modest growth expected, margin pressure looming and cost initiatives plus MedSurg momentum shaping results outlook.

DENTSPLY SIRONA to Post Q1 Earnings: What's in Store for the Stock?

XRAY heads into Q1 earnings with U.S. softness, tariff pressure and transformation costs weighing on margins as investors watch for signs of stabilization.

Can Strong Growth Aid INNV's Q3 Earnings Amid Margin Seasonality? 

InnovAge heads into fiscal Q3 earnings with strong growth momentum and margin gains, but seasonal cost pressures and fading Medicaid tailwinds may temper near-term upside.

Revvity to Report Q1 Earnings: What's in Store for the Stock?

RVTY heads into Q1 earnings with Diagnostics strength and Life Sciences stabilization, but China pressures and weak academic demand may temper near-term growth.

Microbot Medical (NASDAQ:MBOT) Cut to "Strong Sell" at Wall Street Zen

Wall Street Zen downgraded Microbot Medical from a "sell" rating to a "strong sell" rating in a research note on Saturday...

Stryker to Report Q1 Earnings: What's in Store for the Stock?

SYK heads into Q1 earnings with strong procedure demand and robotic surgery growth, but tariff and cost pressures may test margins.

Microbot Medical, Inc. is a medical device company, which engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. It carries out its operations through the ViRob and TipCat platforms. The ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt, a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid shunt system and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCat platform, a self-propelling, flexible, and semi-disposable endoscope, provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. The company was founded by Harel Gadot, Moshe Shoham, and Yosseph Bornstein on August 2, 1988 and is headquartered in Hingham, MA.

Microbot Medical Inc

MBOT Stock Falls As Investors Ponder Impact Of Geopolitical Tensions On Israel-Founded Company

Equity

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$1.86
Prev Close	$1.88
Open	$1.88
Dividend Yield	0.00%
50-Day Moving Average	$2.04
Beta	1.57
Avg. Volume	2.08M
PE Ratio	-6.73

52-Week High	$4.67
52-Week Low	$1.60
Market Capitalization	$124.93M
EPS (Annual)	-$0.287
Price to Book	1.69
Revenue Per Employee	$0.00

MBOTMicrobot Medical Inc

Fundamentals

Feed

News

Sentiment

Fundamentals

Info

Latest MBOT News